Breast Cancer Research

official impact factor 5.79

Open Access Highly Access Research article

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

Richard S Finn1*, Judy Dering1, Dylan Conklin1, Ondrej Kalous1, David J Cohen1, Amrita J Desai1, Charles Ginther1, Mohammad Atefi1, Isan Chen2, Camilla Fowst3, Gerret Los2 and Dennis J Slamon1

Author Affiliations

1 Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, 10833 Le Conte Ave, 11-934 Factor Bldg, Los Angeles, CA 90095, USA

2 Pfizer Global Research and Development, Pfizer Inc., 10724 Science Center Drive, San Diego, CA 92121, USA

3 Pfizer Oncology BU, Clinical Development, Pfizer Inc., Via Lorenteggio 257, Milan 20152, Italy

For all author emails, please log on.

Breast Cancer Research 2009, 11:R77 doi:10.1186/bcr2419


See related editorial by Sutherland and Musgrove, http://breast-cancer-research.com/content/11/6/112

Published: 29 October 2009

Additional files

Additional file 1:

Excel file containing a table that lists the genes from the ANOVA of sensitive cell lines versus resistant cell lines.

Format: XLS Size: 342KB Download file

This file can be viewed with: Microsoft Excel Viewer

Open Data

Additional file 2:

PowerPoint file containing a figure that shows a Venn diagram demonstrating the overlap between resistant and nonluminal markers in breast cancer cell lines.

Format: PPT Size: 127KB Download file

This file can be viewed with: Microsoft PowerPoint Viewer

Open Data

Additional file 3:

PowerPoint file containing a figure that shows a Venn diagram demonstrating the overlap between sensitive and luminal markers in breast cancer cell lines.

Format: PPT Size: 132KB Download file

This file can be viewed with: Microsoft PowerPoint Viewer

Open Data

Additional file 4:

PowerPoint file containing a figure that shows a cluster of differentially expressed genes between the sensitive and resistant cell lines that excludes genes associated with cell subtype.

Format: PPT Size: 593KB Download file

This file can be viewed with: Microsoft PowerPoint Viewer

Open Data

Additional file 5:

PowerPoint file containing a figure that shows a cycle analysis of PD 0332991 in combination with tamoxifen.

Format: PPT Size: 83KB Download file

This file can be viewed with: Microsoft PowerPoint Viewer

Open Data

Additional file 6:

PowerPoint file containing a figure that shows a cycle analysis of PD 0332991 in combination with trastuzumab.

Format: PPT Size: 98KB Download file

This file can be viewed with: Microsoft PowerPoint Viewer

Open Data